[ad_1] July 25, 2018
Read More »Escitalopram reduces the risk of MASC in depressed patients with ACS
Escitalopram reduces the risk of MACE in depressed patients with ACS
[ad_1] (HealthDay) -For patients with depression as a result of recent coronary syndrome (SCA) , escitalopram reduces the risk of major adverse cardiac events (MACE) compared with placebo. a study published in …
Read More »